妇产科指南

订阅

MedSci主页 / 所有栏目 / 妇产科指南

高龄妇女瘢痕子宫再妊娠管理专家共识（2021年版）

2021-05-02 "高龄产妇妊娠期并发症防治策略研究"项目专家组 中国实用妇科与产科杂志

瘢痕子宫妊娠

因为剖宫产术和育龄妇女子宫肌瘤剔除术的广泛开展,随着"全面二孩"政策的实施,合并瘢痕子宫的高龄孕妇显著增多。

中文标题：

高龄妇女瘢痕子宫再妊娠管理专家共识（2021年版）

发布机构：

"高龄产妇妊娠期并发症防治策略研究"项目专家组

发布日期：

2021-05-02

简要介绍：

因为剖宫产术和育龄妇女子宫肌瘤剔除术的广泛开展,随着"全面二孩"政策的实施,合并瘢痕子宫的高龄孕妇显著增多。高龄妇女瘢痕子宫再妊娠相关并发症多为危急重症,严重威胁母儿健康,但我国目前尚缺乏针对高龄妇女的瘢痕子宫再妊娠孕前风险评估及孕期与分娩期分级预警体系。为强化高龄妇女瘢痕子宫再妊娠临床管理,预防和减少相关并发症,国家科技部重点研发计划"高龄产妇妊娠期并发症防治策略研究"项目组探索并制定了适宜基层医院推广应用的高龄瘢痕子宫再妊娠预警评分与分级管理共识。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=高龄妇女瘢痕子宫再妊娠管理专家共识_2021年版.pdf)] GetToolGuiderByIdResponse(projectId=1, id=914b71c00219902d, title=高龄妇女瘢痕子宫再妊娠管理专家共识（2021年版）, enTitle=, guiderFrom=中国实用妇科与产科杂志, authorId=0, author=, summary=因为剖宫产术和育龄妇女子宫肌瘤剔除术的广泛开展,随着"全面二孩"政策的实施,合并瘢痕子宫的高龄孕妇显著增多。, cover=https://img.medsci.cn/2021101/1633094112507_5579292.jpg, journalId=0, articlesId=null, associationId=1993, associationName="高龄产妇妊娠期并发症防治策略研究"项目专家组, associationIntro="高龄产妇妊娠期并发症防治策略研究"项目专家组, copyright=0, guiderPublishedTime=Sun May 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">因为剖宫产术和育龄妇女子宫肌瘤剔除术的广泛开展,随着"全面二孩"政策的实施,合并瘢痕子宫的高龄孕妇显著增多。高龄妇女瘢痕子宫再妊娠相关并发症多为危急重症,严重威胁母儿健康,但我国目前尚缺乏针对高龄妇女的瘢痕子宫再妊娠孕前风险评估及孕期与分娩期分级预警体系。为强化高龄妇女瘢痕子宫再妊娠临床管理,预防和减少相关并发症,国家科技部重点研发计划"高龄产妇妊娠期并发症防治策略研究"项目组探索并制定了适宜基层医院推广应用的高龄瘢痕子宫再妊娠预警评分与分级管理共识。&nbsp;</span></p>, tagList=[TagDto(tagId=115493, tagName=瘢痕子宫妊娠)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=59155, guiderKeyword=高龄妊娠, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4766, appHits=300, showAppHits=0, pcHits=1825, showPcHits=4466, likes=1, shares=38, comments=18, approvalStatus=1, publishedTime=Fri Oct 01 21:25:29 CST 2021, publishedTimeString=2021-05-02, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Oct 01 21:17:20 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 07:11:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高龄妇女瘢痕子宫再妊娠管理专家共识_2021年版.pdf)])
高龄妇女瘢痕子宫再妊娠管理专家共识_2021年版.pdf
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1224319, encodeId=aa9e122431901, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Fri Jun 03 22:51:05 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217594, encodeId=9e95121e594bf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Sat May 07 12:09:50 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203535, encodeId=a5c612035353e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f066481273, createdName=ms5000000970124719, createdTime=Thu Mar 17 19:02:18 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197630, encodeId=c048119e630ce, content=实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a711556987, createdName=yuxingrong, createdTime=Sat Feb 26 22:45:14 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192822, encodeId=8ff811928222b, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sat Feb 12 23:05:56 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-06-03 120c570cm03暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1224319, encodeId=aa9e122431901, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Fri Jun 03 22:51:05 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217594, encodeId=9e95121e594bf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Sat May 07 12:09:50 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203535, encodeId=a5c612035353e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f066481273, createdName=ms5000000970124719, createdTime=Thu Mar 17 19:02:18 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197630, encodeId=c048119e630ce, content=实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a711556987, createdName=yuxingrong, createdTime=Sat Feb 26 22:45:14 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192822, encodeId=8ff811928222b, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sat Feb 12 23:05:56 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-05-07 145c4511m52暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1224319, encodeId=aa9e122431901, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Fri Jun 03 22:51:05 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217594, encodeId=9e95121e594bf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Sat May 07 12:09:50 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203535, encodeId=a5c612035353e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f066481273, createdName=ms5000000970124719, createdTime=Thu Mar 17 19:02:18 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197630, encodeId=c048119e630ce, content=实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a711556987, createdName=yuxingrong, createdTime=Sat Feb 26 22:45:14 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192822, encodeId=8ff811928222b, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sat Feb 12 23:05:56 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-03-17 ms5000000970124719

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1224319, encodeId=aa9e122431901, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Fri Jun 03 22:51:05 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217594, encodeId=9e95121e594bf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Sat May 07 12:09:50 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203535, encodeId=a5c612035353e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f066481273, createdName=ms5000000970124719, createdTime=Thu Mar 17 19:02:18 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197630, encodeId=c048119e630ce, content=实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a711556987, createdName=yuxingrong, createdTime=Sat Feb 26 22:45:14 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192822, encodeId=8ff811928222b, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sat Feb 12 23:05:56 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-26 yuxingrong

    实用，谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1224319, encodeId=aa9e122431901, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Fri Jun 03 22:51:05 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217594, encodeId=9e95121e594bf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Sat May 07 12:09:50 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203535, encodeId=a5c612035353e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f066481273, createdName=ms5000000970124719, createdTime=Thu Mar 17 19:02:18 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197630, encodeId=c048119e630ce, content=实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a711556987, createdName=yuxingrong, createdTime=Sat Feb 26 22:45:14 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192822, encodeId=8ff811928222b, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sat Feb 12 23:05:56 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-12 陌上咖啡

    很有用！

    0

以上为热门评论，梅斯医学App还有更多内容